[{"address1": "11085 Torreyana Road", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 558 0708", "fax": "858 558 0709", "website": "https://www.bioatla.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. The company's lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for treating undifferentiated pleomorphic sarcoma and non-small cell lung cancer (NSCLC); and ozuriftabmab vedotin (BA3021), a CAB ADC to treat melanoma and squamous cell carcinoma of head and neck. It is also developing Evalstotug (BA3071), a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for treating melanoma, renal cell carcinoma, colorectal cancer, and NSCLC; BA3182, a bispecific candidate to treat adenocarcinomas; BA3361, a CAB-Nectin-4-ADC for treating tumors; BA3142, a dual-CAB T-cell engager targeting B7-H3, a protein expressed on various solid tumors; and preclinical candidate for CAB-Nectin 4 x CAB-CD3. The company was founded in 2007 and is headquartered in San Diego, California.", "fullTimeEmployees": 61, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jay M. Short Ph.D.", "age": 66, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 1010378, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard A. Waldron", "age": 70, "title": "Senior VP & CFO", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 600800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Eric L. Sievers M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 637775, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christian J. Vasquez CPA", "age": 48, "title": "Chief Accounting Officer, Controller and Corporate Secretary", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 408745, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susie  Melody", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cathy  Chang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gerhard  Frey Ph.D.", "title": "Senior Vice President of Technology Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Monica  Sullivan", "title": "Senior Vice President of Intellectual Property & Contracts", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sheri  Lydick", "title": "Chief Commercial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lisa M. Pelton", "title": "Accounting Manager", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 8, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.8507, "open": 0.8512, "dayLow": 0.84, "dayHigh": 0.9798, "regularMarketPreviousClose": 0.8507, "regularMarketOpen": 0.8512, "regularMarketDayLow": 0.84, "regularMarketDayHigh": 0.9798, "payoutRatio": 0.0, "beta": 1.026, "forwardPE": -0.614966, "volume": 1032942, "regularMarketVolume": 1032942, "averageVolume": 1461833, "averageVolume10days": 3316630, "averageDailyVolume10Day": 3316630, "bid": 0.8617, "ask": 0.9565, "bidSize": 9, "askSize": 9, "marketCap": 53148048, "fiftyTwoWeekLow": 0.24, "fiftyTwoWeekHigh": 1.74, "allTimeHigh": 76.63, "allTimeLow": 0.24, "priceToSalesTrailing12Months": "Infinity", "fiftyDayAverage": 0.76128, "twoHundredDayAverage": 0.495245, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 51009048, "profitMargins": 0.0, "floatShares": 46232334, "sharesOutstanding": 58792088, "sharesShort": 4783598, "sharesShortPriorMonth": 3000731, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.08140001, "heldPercentInsiders": 0.10569999, "heldPercentInstitutions": 0.2873, "shortRatio": 3.66, "shortPercentOfFloat": 0.0912, "impliedSharesOutstanding": 58792088, "bookValue": -0.531, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -64707000, "trailingEps": -1.15, "forwardEps": -1.47, "enterpriseToEbitda": -0.783, "52WeekChange": -0.49041915, "SandP52WeekChange": 0.1265819, "quoteType": "EQUITY", "currentPrice": 0.904, "targetHighPrice": 10.0, "targetLowPrice": 10.0, "targetMeanPrice": 10.0, "targetMedianPrice": 10.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 8320000, "totalCashPerShare": 0.142, "ebitda": -65112000, "totalDebt": 6181000, "quickRatio": 0.463, "currentRatio": 0.538, "totalRevenue": 0, "revenuePerShare": 0.0, "returnOnAssets": -1.05085, "grossProfits": -46728000, "freeCashflow": -32930750, "operatingCashflow": -57072000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCAB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 6.26542, "regularMarketPrice": 0.904, "marketState": "CLOSED", "shortName": "BioAtla, Inc.", "longName": "BioAtla, Inc.", "exchange": "NCM", "messageBoardId": "finmb_105291463", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": 12.831858, "postMarketPrice": 1.02, "postMarketChange": 0.116, "regularMarketChange": 0.0533, "regularMarketDayRange": "0.84 - 0.9798", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1461833, "fiftyTwoWeekLowChange": 0.664, "fiftyTwoWeekLowChangePercent": 2.7666667, "fiftyTwoWeekRange": "0.24 - 1.74", "fiftyTwoWeekHighChange": -0.836, "fiftyTwoWeekHighChangePercent": -0.48045978, "fiftyTwoWeekChangePercent": -49.041916, "earningsTimestamp": 1763067600, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "earningsCallTimestampStart": 1763069400, "earningsCallTimestampEnd": 1763069400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.15, "epsForward": -1.47, "epsCurrentYear": -1.065, "priceEpsCurrentYear": -0.8488262, "fiftyDayAverageChange": 0.14271998, "fiftyDayAverageChangePercent": 0.18747371, "twoHundredDayAverageChange": 0.40875497, "twoHundredDayAverageChangePercent": 0.8253591, "priceToBook": -1.7024481, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-12-16", "averageAnalystRating": "2.0 - Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1608129000000, "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1764367144, "regularMarketTime": 1764352801, "displayName": "BioAtla", "trailingPegRatio": null, "__fetch_time": "2025-11-29"}]